Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Equifax (EFX) Stock Forecast & Price Target

Equifax logo
$243.77 -2.21 (-0.90%)
Closing price 03:59 PM Eastern
Extended Trading
$247.49 +3.72 (+1.53%)
As of 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Equifax - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Moderate Buy
Based on 19 Analyst Ratings
Sell
0
Hold
6
Buy
13

Based on 19 Wall Street analysts who have issued ratings for Equifax in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 6 have given a hold rating, 12 have given a buy rating, and 1 has given a strong buy rating for EFX.

Consensus Price Target

$283.53
16.31% Upside
According to the 19 analysts' twelve-month price targets for Equifax, the average price target is $283.53. The highest price target for EFX is $305.00, while the lowest price target for EFX is $240.00. The average price target represents a forecasted upside of 16.31% from the current price of $243.77.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for EFX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Equifax and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EFX Analyst Ratings Over Time

TypeCurrent Forecast
8/28/24 to 8/28/25		1 Month Ago
7/29/24 to 7/29/25		3 Months Ago
5/30/24 to 5/30/25		1 Year Ago
8/29/23 to 8/28/24
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
12 Buy rating(s)
12 Buy rating(s)
13 Buy rating(s)
13 Buy rating(s)
Hold
6 Hold rating(s)
7 Hold rating(s)
5 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$283.53$285.00$294.44$292.00
Forecasted Upside16.31% Upside15.41% Upside11.36% Upside-3.83% Downside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

EFX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

EFX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Equifax Stock vs. The Competition

TypeEquifaxBusiness Services CompaniesS&P 500
Consensus Rating Score
2.74
2.70
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside16.31% Upside105.79% Upside10.25% Upside
News Sentiment Rating
Positive News

See Recent EFX News
Positive News
Positive News
Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/23/2025UBS Group
3 of 5 stars		Kevin McVeigh
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetBuy ➝ Buy$315.00 ➝ $278.00+13.79%
7/23/2025Citigroup
2 of 5 stars		Arthur Truslove
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetBuy ➝ Buy$294.00 ➝ $290.00+17.77%
7/23/2025BMO Capital Markets
4 of 5 stars		Jeffrey Silber
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetMarket Perform ➝ Market Perform$280.00 ➝ $260.00+5.70%
7/23/2025Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Owen Lau
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetOutperform ➝ Outperform$296.00 ➝ $279.00+13.57%
7/23/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Andrew Steinerman
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetOverweight ➝ Overweight$277.00 ➝ $272.00+11.68%
7/23/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Jason Haas
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetOverweight ➝ Overweight$310.00 ➝ $300.00+23.53%
7/23/2025Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Jeffrey Meuler
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetOutperform ➝ Outperform$310.00 ➝ $289.00+20.86%
7/23/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Manav Patnaik
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetEqual Weight ➝ Equal Weight$260.00 ➝ $240.00+0.37%
6/23/2025Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Heather Balsky
Subscribe to MarketBeat All Access for the recommendation accuracy rating		DowngradeBuy ➝ Neutral$300.00 ➝ $285.00+11.63%
6/20/2025Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Mayank Tandon
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingBuy ➝ Buy$295.00+16.37%
6/18/2025Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Shlomo Rosenbaum
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetBuy ➝ Buy$277.00 ➝ $295.00+15.31%
6/18/2025Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating		A. Sabadra
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingOutperform ➝ Outperform$300.00+17.51%
6/10/2025Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Toni Kaplan
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingOverweight ➝ Overweight$295.00 ➝ $305.00+11.76%
3/14/2025BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating		A. Grobler
Subscribe to MarketBeat All Access for the recommendation accuracy rating		DowngradeOutperform ➝ Neutral$265.00+11.75%
2/18/2025Gordon Haskett
Subscribe to MarketBeat All Access for the recommendation accuracy rating		C. Grom
Subscribe to MarketBeat All Access for the recommendation accuracy rating		UpgradeStrong-Buy
2/11/2025Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		J. Eade
Subscribe to MarketBeat All Access for the recommendation accuracy rating		DowngradeBuy ➝ Hold
2/7/2025William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingOutperform
1/15/2025Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Surinder Thind
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetBuy ➝ Buy$340.00 ➝ $300.00+13.77%
12/12/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating		S. Wurtzel
Subscribe to MarketBeat All Access for the recommendation accuracy rating		DowngradeOutperform ➝ Peer Perform
8/20/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetNeutral ➝ Neutral$277.00 ➝ $307.00+4.23%
2/13/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeIn-Line ➝ Outperform$210.00 ➝ $310.00+21.21%
2/9/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetBuy ➝ Buy$270.00 ➝ $285.00+14.38%
1/11/2024Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeBuy ➝ Neutral$272.00+11.10%
12/8/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeHold ➝ Buy$218.00 ➝ $267.00+19.05%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 11:26 PM ET.


Should I Buy Equifax Stock? EFX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, August 27, 2025. Please send any questions or comments about these Equifax pros and cons to contact@marketbeat.com.

Equifax
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Equifax Inc.:

  • Equifax Inc. reported earnings per share of $2.00 for the latest quarter, exceeding analysts' expectations, which indicates strong financial performance and potential for growth.
  • The company has shown a year-over-year revenue increase of 7.4%, suggesting a positive trend in business operations and market demand for its services.
  • Equifax Inc. has set a solid guidance for Q3 2025, projecting earnings per share between 1.870 and 1.970, which reflects confidence in future profitability.
  • The current stock price is around $241, which may present a buying opportunity for investors looking to enter at a favorable valuation.
  • With a dividend yield of 0.8% and a payout ratio of 39.14%, Equifax Inc. offers a steady income stream for investors while maintaining a healthy balance for reinvestment in growth.

Equifax
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Equifax Inc. for these reasons:

  • Insider selling activity, including a significant sale by the CEO, may raise concerns about the company's future prospects and management's confidence in the stock.
  • Analysts have varied opinions on the stock, with some reducing their price targets, indicating uncertainty about its future performance.
  • The stock has seen a decrease in ownership by insiders, which could suggest a lack of confidence from those closest to the company.
  • Equifax Inc. operates in a competitive industry, and any shifts in market dynamics could impact its revenue and profitability.
  • The company's net margin of 10.95% may not be as robust compared to industry peers, potentially limiting its competitive edge.

EFX Forecast - Frequently Asked Questions

According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Equifax is $283.53, with a high forecast of $305.00 and a low forecast of $240.00.

19 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Equifax in the last twelve months. There are currently 6 hold ratings, 12 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" EFX shares.

According to analysts, Equifax's stock has a predicted upside of 16.31% based on their 12-month stock forecasts.

Over the previous 90 days, Equifax's stock had 1 downgrade by analysts.

Analysts like Equifax more than other "business services" companies. The consensus rating score for Equifax is 2.74 while the average consensus rating score for "business services" companies is 2.70. Learn more on how EFX compares to other companies.

Related Companies
Today's Ratings
Top-Rated Stocks
More Ratings Tools

This page (NYSE:EFX) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsoredtc pixel
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...
Brownstone Research | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
What Are Some Strategies to Help Lower RMD Taxes?
Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...
SmartAsset | Sponsoredtc pixel
NVIDIA's Worst Nightmare?
$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...
The Oxford Club | Sponsoredtc pixel
Think you missed gold’s boom? Think again
If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...
Investors Alley | Sponsoredtc pixel
Trump’s national nightmare is here
AI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...
Porter & Company | Sponsoredtc pixel